mhurhangee/patent-ind-claim-en huggingface dataset:
A drug administration apparatus that has a formulation syringe formed as a transparent container containing formulation mounted inside and that is adapted to administer drug to a living body, the drug administration apparatus comprising: an identification section, comprising a microprocessor , adapted to identify formulation loaded in the formulation syringe , or a container containing the formulation ; and a reporting section adapted to report a result of identification by the identification section; characterized by a syringe cover that is configured to cover the formulation syringe , wherein the syringe cover has a first opening and a second opening , the first opening and the second opening are configured so as to allow light to pass through the formulation loaded in the formulation syringe , or through the container containing the formulation , when the formulation syringe is mounted in the drug administration apparatus , wherein the identification section has a transmissive color detecting section adapted to detect a color by detecting the light passed through the formulation contained in the formulation syringe or the container containing the formulation , and the microprocessor is configured to determine whether a color data of the color detected with the transmissive color detecting section is within a reference value, wherein the transmissive color detecting section comprises a LED configured to output white light containing RGB components and a color sensor configured to perform digital-conversion on the passed light and output the result to microprocessor , and wherein the first opening and the second opening match the LED and the color sensor , respectively. an identification section, comprising a microprocessor , adapted to identify formulation loaded in the formulation syringe , or a container containing the formulation ; and a reporting section adapted to report a result of identification by the identification section; characterized by a syringe cover that is configured to cover the formulation syringe , wherein the syringe cover has a first opening and a second opening , the first opening and the second opening are configured so as to allow light to pass through the formulation loaded in the formulation syringe , or through the container containing the formulation , when the formulation syringe is mounted in the drug administration apparatus , wherein the identification section has a transmissive color detecting section adapted to detect a color by detecting the light passed through the formulation contained in the formulation syringe or the container containing the formulation , and the microprocessor is configured to determine whether a color data of the color detected with the transmissive color detecting section is within a reference value, wherein the transmissive color detecting section comprises a LED configured to output white light containing RGB components and a color sensor configured to perform digital-conversion on the passed light and output the result to microprocessor , and wherein the first opening and the second opening match the LED and the color sensor , respectively.
A method for synchronizing time between a master hardware clock and one or more client hardware clocks, the method comprising: receiving, by one or more processors of a client hardware clock, a time sync message; performing, by the one or more processors, a validity check on the time sync message; updating, by the one or more processors, a time of the client hardware clock in response to the received time sync message passing the validity check; incrementing, by the one or more processors, a valid update count in response to the received time sync message passing the validity check; and locking, by the one or more processors, the time of the client hardware clock to be within a threshold range from the master hardware clock, in response to the valid update count incrementing above a threshold. receiving, by one or more processors of a client hardware clock, a time sync message; performing, by the one or more processors, a validity check on the time sync message; updating, by the one or more processors, a time of the client hardware clock in response to the received time sync message passing the validity check; incrementing, by the one or more processors, a valid update count in response to the received time sync message passing the validity check; and locking, by the one or more processors, the time of the client hardware clock to be within a threshold range from the master hardware clock, in response to the valid update count incrementing above a threshold.
A method of producing 1-aminocyclopropanecarboxylic acid non-hydrate, which comprises treating 1-aminocyclopropanecarboxylic acid hydrochloride with a tertiary amine in the presence of a C 3 -C 4 alcohol and water, keeping the reaction mixture at 50°C or below, collecting the precipitated crystal of 1-aminocyclopropanecarboxylic acid 0.5 hydrate by filtration, and heating the obtained crystal to 80 to 245°C. treating 1-aminocyclopropanecarboxylic acid hydrochloride with a tertiary amine in the presence of a C 3 -C 4 alcohol and water, keeping the reaction mixture at 50°C or below, collecting the precipitated crystal of 1-aminocyclopropanecarboxylic acid 0.5 hydrate by filtration, and heating the obtained crystal to 80 to 245°C.
An isolated monoclonal antibody that binds to human immunodeficiency virus (HIV) gp120, wherein the antibody comprises: i. the heavy chain sequence set forth in SEQ ID NO: 273 and the light chain sequence set forth in SEQ ID NO: 359; ii. the heavy chain sequence set forth in SEQ ID NO: 252 and the light chain sequence set forth in SEQ ID NO: 338; iii. the heavy chain sequence set forth in SEQ ID NO: 255 and the light chain sequence set forth in SEQ ID NO: 341; iv. the heavy chain sequence set forth in SEQ ID NO: 266 and the light chain sequence set forth in SEQ ID NO: 352; v. the heavy chain sequence set forth in SEQ ID NO: 267 and the light chain sequence set forth in SEQ ID NO: 353; or vi. the heavy chain sequence set forth in SEQ ID NO: 272 and the light chain sequence set forth in SEQ ID NO: 358. i. the heavy chain sequence set forth in SEQ ID NO: 273 and the light chain sequence set forth in SEQ ID NO: 359; ii. the heavy chain sequence set forth in SEQ ID NO: 252 and the light chain sequence set forth in SEQ ID NO: 338; iii. the heavy chain sequence set forth in SEQ ID NO: 255 and the light chain sequence set forth in SEQ ID NO: 341; iv. the heavy chain sequence set forth in SEQ ID NO: 266 and the light chain sequence set forth in SEQ ID NO: 352; v. the heavy chain sequence set forth in SEQ ID NO: 267 and the light chain sequence set forth in SEQ ID NO: 353; or vi. the heavy chain sequence set forth in SEQ ID NO: 272 and the light chain sequence set forth in SEQ ID NO: 358.
Eyewear for viewing 3D images, each 3D image including a left eye image comprising left eye spectral bands and a right eye image comprising right eye spectral bands separated from the left eye spectral bands, said eyewear including: a left lens including a first set of spectral filters adapted to pass the left eye spectral bands of said left eye images and to block the right eye spectral bands of said right eye images; a right lens including a second set of spectral filters adapted to pass the right eye spectral bands of said right eye images and to block the left eye spectral bands of said left eye images; wherein said left lens and said right lens each include an optical coating and a thickness of said optical coating is greater near edges of said left lens and said right lens than near the center of said left lens and said right lens, and a frame for holding said left lens and said right lens, said frame including one or more positioning surfaces disposed to abut the face of a wearer, wherein said positioning surfaces include a nose piece that is mounted to said frame at an adjustable position relative to said frame to position said left lens and said right lens within a predetermined distance from left and right eyes, respectively, of said wearer of 15-20mm,wherein said nose piece is mounted to said frame via a fastener passing through a hole in said frame, wherein said fastener threads into a threaded opening in said nose piece, and wherein said frame further comprises an adjustment wheel forming a threaded engagement with said fastener to adjust said position of said nose piece relative to said frame, wherein the thickness of said optical coating and the predetermined distance are arranged for preventing crosstalk between the left eye image and the right eye image and wherein the thickness of the optical coating is arranged to maintain desired passbands of the first and second set of spectral filters for average viewing angles associated with particular positions on the lens, in as much as the positioning surfaces prevent an exacerbated angular obliqueness at which light passes through the left and right lenses, due to the left and right lenses being positioned too close the left and right eyes of the wearer. a left lens including a first set of spectral filters adapted to pass the left eye spectral bands of said left eye images and to block the right eye spectral bands of said right eye images; a right lens including a second set of spectral filters adapted to pass the right eye spectral bands of said right eye images and to block the left eye spectral bands of said left eye images; wherein said left lens and said right lens each include an optical coating and a thickness of said optical coating is greater near edges of said left lens and said right lens than near the center of said left lens and said right lens, and
Method for detecting a local change in refractive index of a dielectric medium located on the surface of an optical sensor, said optical sensor comprising for this purpose either a waveguide comprising a region, called the active region, covered with at least one metallic and/or dielectric layer in contact with the dielectric medium, or a waveguide facing another waveguide, this other waveguide forming a resonator and constituting a region, called the active region, in contact with the dielectric medium, said method comprising the following steps: a) emitting a light beam at the input of the waveguide so that this light beam can be propagated, within the waveguide, according to at least N propagation modes, where N is a natural integer such that N ≥ 2, towards the active region; the light beam reflected or transmitted by the active region thus presenting a given spatial distribution of the intensity; b) measuring, on at least one zone of the spatial distribution of the intensity of the light beam reflected or transmitted by said active region of the optical sensor which only takes into account one part of said spatial distribution, the intensity on the said at least one zone; and c) detecting the local change in the refractive index of the dielectric medium by means of a database supplying the link between the intensity of said at least one zone of the spatial distribution of the intensity of the light beam reflected or transmitted by the active region of the optical sensor and a change in refractive index relative to a reference medium. a) emitting a light beam at the input of the waveguide so that this light beam can be propagated, within the waveguide, according to at least N propagation modes, where N is a natural integer such that N ≥ 2, towards the active region; the light beam reflected or transmitted by the active region thus presenting a given spatial distribution of the intensity; b) measuring, on at least one zone of the spatial distribution of the intensity of the light beam reflected or transmitted by said active region of the optical sensor which only takes into account one part of said spatial distribution, the intensity on the said at least one zone; and c) detecting the local change in the refractive index of the dielectric medium by means of a database supplying the link between the intensity of said at least one zone of the spatial distribution of the intensity of the light beam reflected or transmitted by the active region of the optical sensor and a change in refractive index relative to a reference medium.
A waste heat recovery apparatus suitable for recovering energy from waste heat of internal combustion engines, the apparatus comprising: a working fluid circuit to circulate working fluid; a boiler connected on the working fluid circuit and adapted to recover waste heat from a source and transfer recovered waste heat to the working fluid; an expander connected on the working fluid circuit to receive working fluid from the boiler ; a condenser connected on the working fluid circuit to receive working fluid from the expander , a pump connected on the working fluid circuit to receive working fluid exiting the condenser and direct the working fluid under pressure to the boiler , and, a mixer connected on the working fluid circuit downstream of the expander and upstream of the condenser , the working fluid circuit having a line connected downstream of the condenser to deliver working fluid cooled and condensed by the condenser to the mixer , characterized in that the apparatus comprises a bypass valve disposed on the working fluid circuit between the boiler and the expander and a bypass line connecting the bypass valve and the mixer . a working fluid circuit to circulate working fluid; a boiler connected on the working fluid circuit and adapted to recover waste heat from a source and transfer recovered waste heat to the working fluid; an expander connected on the working fluid circuit to receive working fluid from the boiler ; a condenser connected on the working fluid circuit to receive working fluid from the expander , a pump connected on the working fluid circuit to receive working fluid exiting the condenser and direct the working fluid under pressure to the boiler , and, a mixer connected on the working fluid circuit downstream of the expander and upstream of the condenser , the working fluid circuit having a line connected downstream of the condenser to deliver working fluid cooled and condensed by the condenser to the mixer , characterized in that the apparatus comprises a bypass valve disposed on the working fluid circuit between the boiler and the expander and a bypass line connecting the bypass valve and the mixer .
A method of enriching a lipopeptide in a microbial cell culture, the method comprising: a) mixing an amphiphilic sulfonate of formula (I) wherein R 1 and R 2 are independently a linear or branched C 1-20 alkyl; and M is H + , Li + , Na + , K + or (C 1-8 alkyl) 4 N + . and/or an amphiphilic sulfate of formula (II) wherein R 1 and R 2 are independently a linear or branched C 1-20 alkyl; and M is H + , Li + , Na + , K + or (C 1-8 alkyl) 4 N + with the cell culture to induce the formation of aggregates containing the lipopeptide; b) centrifuging the cell culture to generate a supernatant fraction and a pellet fraction; c) separating the pellet fraction from the supernatant fraction; and d) mixing the pellet fraction with a polyoxyethylene glycol alkyl ether to release the lipopeptide from the aggregates. a) mixing an amphiphilic sulfonate of formula (I) wherein R 1 and R 2 are independently a linear or branched C 1-20 alkyl; and M is H + , Li + , Na + , K + or (C 1-8 alkyl) 4 N + . and/or an amphiphilic sulfate of formula (II) wherein R 1 and R 2 are independently a linear or branched C 1-20 alkyl; and M is H + , Li + , Na + , K + or (C 1-8 alkyl) 4 N + with the cell culture to induce the formation of aggregates containing the lipopeptide; R 1 and R 2 are independently a linear or branched C 1-20 alkyl; and M is H + , Li + , Na + , K + or (C 1-8 alkyl) 4 N + . R 1 and R 2 are independently a linear or branched C 1-20 alkyl; and M is H + , Li + , Na + , K + or (C 1-8 alkyl) 4 N + b) centrifuging the cell culture to generate a supernatant fraction and a pellet fraction; c) separating the pellet fraction from the supernatant fraction; and d) mixing the pellet fraction with a polyoxyethylene glycol alkyl ether to release the lipopeptide from the aggregates.
An LED module comprising - a number of light-emitting diodes arranged on a carrier; and - an encapsulant covering the LEDs , which encapsulant is flexible and comprises a mixture of a flexible translucent constituent ; and a metallic particle constituent , comprising metallic particles configured to scatter light passing through the encapsulant when the LED module is in an inactive state and when the LED module is in an active state, and to impart a desired colour to the LED module when the LED module is in the inactive state, the weight load of the metallic particles of the metallic particle constituent being in a range between 0.001 wt% and 0.5 wt% of the encapsulant . - a number of light-emitting diodes arranged on a carrier; and - an encapsulant covering the LEDs , which encapsulant is flexible and comprises a mixture of a flexible translucent constituent ; and a metallic particle constituent , comprising metallic particles configured to scatter light passing through the encapsulant when the LED module is in an inactive state and when the LED module is in an active state, and to impart a desired colour to the LED module when the LED module is in the inactive state, the weight load of the metallic particles of the metallic particle constituent being in a range between 0.001 wt% and 0.5 wt% of the encapsulant . a flexible translucent constituent ; and a metallic particle constituent , comprising metallic particles configured to scatter light passing through the encapsulant when the LED module is in an inactive state and when the LED module is in an active state, and to impart a desired colour to the LED module when the LED module is in the inactive state, the weight load of the metallic particles of the metallic particle constituent being in a range between 0.001 wt% and 0.5 wt% of the encapsulant .
An implantable device comprising: a housing configured to be implantable at a subcutaneous implant location in a patient; a power supply disposed within the housing; a transmitting coil assembly extending from the housing , the transmitting coil assembly configured to extend from the subcutaneous implant location of the housing to a substernal location, the transmit coil assembly including a transmit coil ; and a controller operably coupled to the power supply and the transmit coil , the controller configured to selectively activate the transmit coil to provide inductive power to a receive coil of a remote medical device implanted substernally. a housing configured to be implantable at a subcutaneous implant location in a patient; a power supply disposed within the housing; a transmitting coil assembly extending from the housing , the transmitting coil assembly configured to extend from the subcutaneous implant location of the housing to a substernal location, the transmit coil assembly including a transmit coil ; and a controller operably coupled to the power supply and the transmit coil , the controller configured to selectively activate the transmit coil to provide inductive power to a receive coil of a remote medical device implanted substernally.
A system for an aircraft , the system comprising: a probe that includes a heater comprising a resistive heating element routed through the probe , wherein an operational voltage is provided to the resistive heating element to provide heating for the probe ; characterised by further comprising: a control circuit configured to provide the operational voltage and monitor a capacitance between the resistive heating element and a metallic sheath of the heater over time; wherein the control circuit is further configured to determine a remaining useful life of the probe based on the capacitance. a probe that includes a heater comprising a resistive heating element routed through the probe , wherein an operational voltage is provided to the resistive heating element to provide heating for the probe ; characterised by further comprising: a control circuit configured to provide the operational voltage and monitor a capacitance between the resistive heating element and a metallic sheath of the heater over time; wherein the control circuit is further configured to determine a remaining useful life of the probe based on the capacitance. a control circuit configured to provide the operational voltage and monitor a capacitance between the resistive heating element and a metallic sheath of the heater over time; wherein the control circuit is further configured to determine a remaining useful life of the probe based on the capacitance.
A method of performing a nucleic acid assay on an automated analyzer, the method comprising the steps of: (a) presenting an interface on a computer enabling a user to use the computer to select, define, or modify one or more user-defined assay parameters of a protocol for extracting, amplifying and detecting a nucleic acid analyte on the analyzer; (b) receiving user-defined assay parameters input to the interface by the user; (c) assembling the protocol from the received user-defined assay parameters combined with one or more system-defined assay parameters; (d) storing the protocol as a series of computer-executable instructions to be executed by the analyzer, wherein the user-defined assay parameters and the system-defined assay parameters of the protocol define steps executed by the analyzer to perform the nucleic acid assay; and (e) executing the computer-executable instructions of the protocol with the analyzer to perform the nucleic acid assay, and collecting assay results data with the analyzer, wherein, the user-defined assay parameters comprise data analysis parameters, wherein the data analysis parameters comprise computer-executable instructions to be executed by a data analysis computer for analyzing the assay results data collected by the analyzer during step (e), and wherein the method further comprises analyzing the assay results data collected during step (e) based on the data analysis parameters. (a) presenting an interface on a computer enabling a user to use the computer to select, define, or modify one or more user-defined assay parameters of a protocol for extracting, amplifying and detecting a nucleic acid analyte on the analyzer; (b) receiving user-defined assay parameters input to the interface by the user; (c) assembling the protocol from the received user-defined assay parameters combined with one or more system-defined assay parameters; (d) storing the protocol as a series of computer-executable instructions to be executed by the analyzer, wherein the user-defined assay parameters and the system-defined assay parameters of the protocol define steps executed by the analyzer to perform the nucleic acid assay; and (e) executing the computer-executable instructions of the protocol with the analyzer to perform the nucleic acid assay, and collecting assay results data with the analyzer,